Peptide Reference
GHRP-2
Growth Hormone Releasing Peptide-2
A second-generation growth hormone releasing peptide more potent than GHRP-6 but with less appetite stimulation. Moderate cortisol and prolactin elevation.
Status
research
Category
growth hormone
Typical cost
$30-60/vial (5mg)
Mechanism
Binds to ghrelin receptors to stimulate GH release. More selective than GHRP-6 with less appetite stimulation. Still elevates cortisol and prolactin moderately.
Potential benefits
- Increased growth hormone
- Moderate appetite increase
- Muscle growth
- Fat loss
- Improved recovery
- Better sleep
- Strong GH release
- Moderate appetite
- Diagnostic use validated
- Less cortisol impact than GHRP-6
Reported side effects
- Increased hunger
- Water retention
- Elevated cortisol
- Raised prolactin
- Injection site reactions
- Mild cortisol elevation
- Some prolactin increase
Common dosing references
subcutaneous
100-300mcg · 2-3x daily
8-12 weeks
subcutaneous
100-300mcg · 1-3x daily
8-12 weeks
Research notes
GHRP-2 pharmacodynamics
1997
More potent GH release than GHRP-6 with reduced appetite effects
GHRP-2 diagnostic use
1997
Validated as GH stimulation test in clinical settings
Regulatory and sourcing notes
Research chemical only. Not FDA-approved. Not available by prescription.
Research peptide only. Intermediate option between GHRP-6 and Ipamorelin.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides